What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Acquired immunodeficiency syndrome
- Cancer
Internal medicine, Immunology, Acquired immunodeficiency syndrome, Cohort study and Viral load are his primary areas of study.
His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology, Sida and Ritonavir.
His study in Immunology is interdisciplinary in nature, drawing from both Proportional hazards model and Pediatrics.
His work carried out in the field of Acquired immunodeficiency syndrome brings together such families of science as Chemoprophylaxis, Surgery, Incidence, Epidemiology and Viral disease.
His biological study spans a wide range of topics, including Kaposi's sarcoma, Mortality rate, Non-Hodgkin's lymphoma, Cohort and Risk factor.
His work on Virus load as part of general Viral load study is frequently linked to Baseline, bridging the gap between disciplines.
His most cited work include:
- Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. (1341 citations)
- Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. (1225 citations)
- Decline in the AIDS and death rates in the EuroSIDA study: an observational study (1070 citations)
What are the main themes of his work throughout his whole career to date?
Bruno Ledergerber mainly investigates Internal medicine, Cohort study, Immunology, Acquired immunodeficiency syndrome and Viral load.
Bruno Ledergerber has researched Internal medicine in several fields, including Gastroenterology and Surgery.
His Cohort study research is multidisciplinary, incorporating elements of Odds ratio, Hazard ratio, Prospective cohort study, Pediatrics and Risk factor.
His research on Immunology often connects related areas such as Rate ratio.
His work deals with themes such as Mortality rate, Pharmacotherapy and Epidemiology, which intersect with Acquired immunodeficiency syndrome.
His studies deal with areas such as Regimen, Viremia and Efavirenz as well as Viral load.
He most often published in these fields:
- Internal medicine (56.70%)
- Cohort study (37.04%)
- Immunology (34.47%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (56.70%)
- Cohort study (37.04%)
- Confidence interval (13.96%)
In recent papers he was focusing on the following fields of study:
Bruno Ledergerber mainly focuses on Internal medicine, Cohort study, Confidence interval, Cohort and Interquartile range.
Bruno Ledergerber has included themes like Gastroenterology and Rifampicin in his Internal medicine study.
His Cohort study research includes themes of Tenofovir alafenamide, Incidence, Hepatitis C, Prospective cohort study and Confounding.
As a part of the same scientific study, Bruno Ledergerber usually deals with the Incidence, concentrating on Surgery and frequently concerns with Antibiotics.
His Confidence interval study combines topics from a wide range of disciplines, such as Standardized uptake value, Therapy control and Viral load.
The concepts of his Cohort study are interwoven with issues in T lymphocyte and Family medicine.
Between 2015 and 2021, his most popular works were:
- Optimal length of cultivation time for isolation of Propionibacterium acnes in suspected bone and joint infections is more than 7 days (54 citations)
- Subclinical coronary artery disease in Swiss HIV-positive and HIV-negative persons. (29 citations)
- Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in Europe. (28 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Acquired immunodeficiency syndrome
- Cancer
His main research concerns Cohort study, Internal medicine, Cohort, Immunology and Confidence interval.
His Cohort study research is multidisciplinary, relying on both Leukemia, Chronic lymphocytic leukemia, Artificial intelligence and Risk of infection.
His Internal medicine research is multidisciplinary, incorporating perspectives in Surgery, Isoniazid, Rifampicin, Tuberculosis and Gastroenterology.
In his work, Poisson regression, Prospective cohort study, Kidney disease and Diabetes mellitus is strongly intertwined with Incidence, which is a subfield of Surgery.
His Immunology study integrates concerns from other disciplines, such as Nevirapine and Efavirenz.
His Confidence interval study incorporates themes from Odds ratio, Framingham Risk Score, Young adult, Virological failure and Pediatrics.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
